EW stock forecast
Our latest prediction for Edwards Lifesciences Corp.'s stock price was made on the June 12, 2019 when the stock price was at 184.80$.
In the short term (2weeks), EW's stock price should outperform the market by 0.57%. During that period the price should oscillate between -3.45% and +3.92%.
In the medium term (3months), EW's stock price should outperform the market by 1.27%. During that period the price should oscillate between -8.73% and +11.91%.Get email alerts
About Edwards Lifesciences Corp.
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
At the moment the company generates 3964M USD in revenues.
On its last earning announcement, the company reported a profit of 3.42$ per share.
The book value per share is 15.11$
Three months stock forecastJune 12, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|